Literature DB >> 3003235

Stimulation of helper/delayed-type hypersensitivity T cells by flavivirus infection: determination by macrophage procoagulant assay.

J E Allan, P C Doherty.   

Abstract

West Nile virus (WNV)-immune spleen cells produced an inducer of macrophage procoagulant activity (MPCA) on restimulation with WNV in vitro. This response was specific for WNV and depended on the presence of Thy 1+, L3T4+ and also Ia+ cells but not Lyt 2+ cells. It could be induced by culture with large amounts of non-infectious, u.v.-irradiated virus or with high doses of infectious virus. Inoculation of mice with low titres of infectious, but not with u.v.-irradiated, virus primed for this in vitro response. The time of maximum production of procoagulant-inducing factor was also the period of greatest [3H]thymidine uptake and release of interleukin-2 (IL-2)-like activity. In bulk cultures, MPCA-inducing factor was more readily quantified than IL-2. T cells of the helper/delayed-type hypersensitivity class are thus stimulated by WNV and this aspect of cell-mediated immunity can be readily assayed in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003235     DOI: 10.1099/0022-1317-67-1-39

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.

Authors:  J T Roehrig; A J Johnson; A R Hunt; B J Beaty; J H Mathews
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.

Authors:  J H Mathews; J E Allan; J T Roehrig; J R Brubaker; M F Uren; A R Hunt
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Absence of monocyte procoagulant activity during the immune response to influenza virus.

Authors:  M Mathies; N Hogg
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.